The Shifting Landscape of US Science Funding
The approach to federal science funding in the United States is undergoing a significant transformation. Recent proposals from the White House aimed to reduce federal science funding from $198 billion (€165 billion) to $154 billion (€129 billion), marking one of the largest cuts since the Second World War.
Whereas the US Senate Appropriations Committee has suggested a smaller reduction—proposing funding at €188 billion (€157 billion)—the overall trend points toward a $30 billion cut in science funding across the board. This shift is not merely financial; it represents a fundamental change in research priorities.
For instance, funding for the green sector has seen dramatic slashes. Solar research funding has been cut by 31% and wind research by 29%. Conversely, coal research has seen a massive increase of 260%, creating a environment where coal scientists are “living in clover” while renewable energy researchers struggle to secure basic support.
Public Health Risks and the Vaccine Debate
One of the most contentious areas of this policy shift is the targeting of vaccine research. US Health Secretary Robert F Kennedy Jr. Has pulled $500 million (€434 million) in funding for mRNA vaccines used to treat infections like COVID-19 and the flu.
This decision has caused “massive unease” within the scientific community, as mRNA technology is considered well-proven and safe. The administration’s claim that these vaccines fail to protect effectively against upper respiratory infections is viewed by experts like Trinity Professor Luke O’Neill as not being backed by data.
The real-world consequences are already appearing. The US is currently facing its biggest measles outbreak since 1991. This is partly attributed to a reduction in the childhood vaccine schedule; while children in Europe may receive 12 to 14 vaccines, the number in the USA has been reduced to seven.
Experts warn that these gaps in immunization will lead to a rise in the incidence of preventable diseases. For those traveling to the United States, there are now urgent recommendations to be fully vaccinated—specifically for measles—similar to how travelers are advised to obtain yellow fever vaccines before visiting Brazil.
The Global Impact: Brain Drain and Eroding Trust
The systemic undermining of science in the US has implications that stretch far beyond American borders. Because diseases like cancer and Alzheimer’s are universal, cuts to US research impact people globally, including those in Ireland.
There is a growing fear that the “war on science” is leading to a significant brain drain. An increasing number of younger scientists are leaving the field entirely due to a lack of support and funding. This exodus threatens the long-term viability of American innovation.
the reshaping of advisory committees—such as the Advisory Committee on Immunisation Practices—is a major point of concern. By disbanding long-standing committees or appointing vaccine skeptics, the administration is seen as denying science rather than listening to it.
The most lasting damage may be the erosion of public trust. When the general public sees science being systematically undermined at the highest levels of government, mistrust becomes a feature of society, making it harder for scientists to communicate vital health and environmental data.
However, a “quiet revolution” is emerging. Approximately 100 different disease advocacy groups and patients have begun lobbying Congressional Republicans, who have in some cases pushed back against the White House’s most severe funding cuts because they recognize the personal value of research into life-threatening diseases.
Frequently Asked Questions
Why are US science cuts affecting people outside the US?
Many global health breakthroughs in areas like cancer and Alzheimer’s research originate in the US. Reductions in this funding sluggish down the development of treatments that the entire world relies on.
What is happening to renewable energy research in the US?
Funding for solar and wind research has been cut by 31% and 29% respectively, while coal research funding has increased by 260%.
Why is there a rise in measles in the US?
The rise is linked to a reduction in the number of recommended childhood vaccines (from 12-14 in Europe to 7 in the US) and a general rise in vaccine skepticism.
Who is leading the opposition to these science cuts in the US?
A coalition of around 100 disease advocacy groups and patients have been effectively lobbying members of Congress to defend research funding.
What do you think about the shift in global science funding? Does the move toward coal research hinder the fight against climate change? Let us know in the comments below or subscribe to our newsletter for more deep dives into global science trends.
